メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

4   !!Link opens in a new tab 被引用数 (Scopus)

抄録

An 81-year-old man was treated with prednisolone, avacopan, and rituximab for microscopic polyangiitis and sulfamethoxazole/trimethoprim (SMX/TMP) and vonoprazan for prophylaxis. The liver enzyme levels were elevated 42 days after avacopan administration. Avacopan, SMX/TMP, and vonoprazan treatment were discontinued. A liver biopsy revealed vanishing bile duct syndrome. The patient was subsequently treated with ursodeoxycholic acid and glucocorticoid. Although vasculitis remained in remission, the patient ultimately died. Autopsy revealed persistent bile ductopenia and progressive liver cell injury confirmed by cytokeratin 7 positivity, severe cholestasis, and portal fibrosis. Further studies are required to elucidate associated mechanisms and risk factors.

本文言語英語
ページ(範囲)1017-1022
ページ数6
ジャーナルInternal Medicine
巻65
号7
DOI
出版ステータス出版済み - 2026

All Science Journal Classification (ASJC) codes

  • 内科学

フィンガープリント

「Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル